The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Tissue-specific Expression of βKlotho and Fibroblast Growth Factor (FGF) Receptor Isoforms Determines Metabolic Activity of FGF19 and FGF21
Open accessAbstract
The fibroblast growth factor (FGF) 19 subfamily of ligands, FGF19, FGF21, and FGF23, function as hormones that regulate bile acid, fatty acid, glucose, and phosphate metabolism in target organs through activating FGF receptors (FGFR1-4). We demonstrated that Klotho and betaKlotho, homologous single-pass transmembrane proteins that bind to FGFRs, are required for metabolic activity of FGF23 and FGF21, respectively. Here we show that, like FGF21, FGF19 also requires betaKlotho. Both FGF19 and FGF21 can signal through FGFR1-3 bound by betaKlotho and increase glucose uptake in adipocytes expressing FGFR1. Additionally, both FGF19 and FGF21 bind to the betaKlotho-FGFR4 complex; however, only FGF19 signals efficiently through FGFR4. Accordingly, FGF19, but not FGF21, activates FGF signaling in hepatocytes that primarily express FGFR4 and reduces transcription of CYP7A1 that encodes the rate-limiting enzyme for bile acid synthesis. We conclude that the expression of betaKlotho, in combination with particular FGFR isoforms, determines the tissue-specific metabolic activities of FGF19 and FGF21.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“loss of KLB abolishes all effects of FGF21 in vitro and in vivo46,53–56.”
From Metabolic messengers: FGF21 (2021) · cites this paper as [46]
In the citing paper
“FGF21 binding promotes the formation of a dimeric FGFR1c–KLB signalling complex, which activates the intracellular tyrosine kinase domains of FGFR1c and propagates signalling through phosphorylation by the kinase ERK46,53,58,59”
From Metabolic messengers: FGF21 (2021) · cites this paper as [46]
In the citing paper
“FGF21 elicits its biological effects by binding and activating a receptor complex composed of the co-receptor KLB and a traditional FGF receptor, fibroblast growth factor receptor 1c (FGFR1c)46,47.”
From Metabolic messengers: FGF21 (2021) · cites this paper as [46]
In the citing paper
“Interestingly, both FGF21 and another endocrine FGF, FGF15/19, share a requirement for KLB for signaling46,54, but what cross-talk, if any, exists between these signalling pathways in both physiological and pharmacological settings is unclear.”
From Metabolic messengers: FGF21 (2021) · cites this paper as [46]
In the citing paper
“FGF21 signals to a receptor complex comprised of FGF receptor 1c (FGFR1c) and its co-receptor β-klotho (KLB) [[143], [144], [145], [146]].”
From Hepatokines and metabolism: Deciphering communication from the liver (2021) · cites this paper as [143]
In the citing paper
“Importantly, since FGF receptors are ubiquitously expressed, endocrine FGFs require a coreceptor to provide signaling specificity, which for FGF21 and FGF19 is the coreceptor β-klotho (71, 99, 140).”
From Fibroblast Growth Factor 21: A Versatile Regulator of Metabolic Homeostasis (2018) · cites this paper as [71]
In the citing paper
“FGF21 functions in target tissues that express the traditional FGF receptor FGFR1c and the obligate coreceptor β-klotho (2, 27, 71, 99, 124, 140).”
From Fibroblast Growth Factor 21: A Versatile Regulator of Metabolic Homeostasis (2018) · cites this paper as [71]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mutation of the mouse klotho gene leads to a syndrome resembling ageing
Kuro-o, M., Matsumura, Y., Aizawa, H., Kawaguchi, H., Suga, T., Utsugi, T., Ohyama, Y., Kurabayashi, M., Kaname, T., Kume, E., et al. (1997) · Nature · doi:10.1038/36285 · Cited by 3,837
Self-citationFGF-21 as a novel metabolic regulator
Kharitonenkov, A., Shiyanova, T. L., Koester, A., Ford, A. M., Micanovic, R., Galbreath, E. J., Sandusky, G. E., Hammond, L. J., Moyers, J. S., Owens, R. A., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23606 · Cited by 2,125
Suppression of Aging in Mice by the Hormone Klotho
Kurosu, H., Yamamoto, M., Clark, J. D., Pastor, J. V., Nandi, A., Gurnani, P., McGuinness, O. P., Chikuda, H., Yamaguchi, M., Kawaguchi, H., et al. (2005) · Science · doi:10.1126/science.1112766 · Cited by 1,935
Self-citationReceptor Specificity of the Fibroblast Growth Factor Family
Ornitz, D. M., Xu, J., Colvin, J. S., McEwen, D. G., MacArthur, C. A., Coulier, F., Gao, G., & Goldfarb, M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.25.15292 · Cited by 1,871
Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis
Inagaki, T., Choi, M., Moschetta, A., Peng, L., Cummins, C. L., McDonald, J. G., Luo, G., Jones, S. A., Goodwin, B., Richardson, J. A., et al. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.09.001 · Cited by 1,865
Self-citationKlotho converts canonical FGF receptor into a specific receptor for FGF23
Urakawa, I., Yamazaki, Y., Shimada, T., Iijima, K., Hasegawa, H., Okawa, K., Fujita, T., Fukumoto, S., & Yamashita, T. (2006) · Nature · doi:10.1038/nature05315 · Cited by 1,865
Inagaki, T., Dutchak, P., Zhao, G., Ding, X., Gautron, L., Parameswara, V., Li, Y., Goetz, R., Mohammadi, M., Esser, V., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.05.003 · Cited by 1,504
Self-citationShimada, T., Kakitani, M., Yamazaki, Y., Hasegawa, H., Takeuchi, Y., Fujita, T., Fukumoto, S., Tomizuka, K., & Yamashita, T. (2004) · Journal of Clinical Investigation · doi:10.1172/jci19081 · Cited by 1,503
Badman, M. K., Pissios, P., Kennedy, A. R., Koukos, G., Flier, J. S., & Maratos-Flier, E. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.05.002 · Cited by 1,495
Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23
White, K., Evans, W. E., O'Riordan, J., Speer, M., Econs, M., Lorenz-Depiereux, B., Grabowski, M., Meitinger, T., & Strom, T. (2000) · Nature Genetics · doi:10.1038/81664 · Cited by 1,467
Flagged first, then by citations
Cited by
Sorted by citations
Items 301–400 of 748
FGF21 acts as a negative regulator of bile acid synthesis
Chen, M. M., Hale, C., Stanislaus, S., Xu, J., & Véniant, M. M. (2018) · Journal of Endocrinology · doi:10.1530/joe-17-0727 · Cited by 51
Enterohepatic circulation of bile acids and their emerging roles on glucolipid metabolism
Chen, M., Liu, C., Wan, Y., Yang, L., Jiang, S., Qian, D., & Duan, J. (2020) · Steroids · doi:10.1016/j.steroids.2020.108757 · Cited by 55
Multi-organ FGF21-FGFR1 signaling in metabolic health and disease
Kaur, N., Gare, S. R., Shen, J., Raja, R., Fonseka, O., & Liu, W. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.962561 · Cited by 49
Flippo, K. H., Jensen-Cody, S. O., Claflin, K. E., & Potthoff, M. J. (2020) · Scientific Reports · doi:10.1038/s41598-020-76593-2 · Cited by 49
Long, X., Liu, D., Gao, Q., Ni, J., Qian, L., Ni, Y., Fang, Q., Jia, W., & Li, H. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.773340 · Cited by 47
Cross-talk between liver and intestine in control of cholesterol and energy homeostasis
Groen, A. K., Bloks, V. W., Verkade, H. J., & Kuipers, F. (2014) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2014.02.001 · Cited by 51
Resident Hepatocyte Fibroblast Growth Factor Receptor 4 Limits Hepatocarcinogenesis
Huang, X., Yang, C., Jin, C., Luo, Y., Wang, F., & Mckeehan, W. (2008) · Molecular Carcinogenesis · doi:10.1002/mc.20494 · Cited by 49
Polanska, U. M., Fernig, D. G., & Kinnunen, T. K. (2008) · Developmental Dynamics · doi:10.1002/dvdy.21757 · Cited by 51
Fibroblast growth factor 21: an overview from a clinical perspective
Rydén, M. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-0003-9 · Cited by 48
Fgf21 is required for cardiac remodeling in pregnancy
Redondo‐Angulo, I., Mas‐Stachurska, A., Sitges, M., Tinahones, F. J., Giralt, M., Villarroya, F., & Planavila, A. (2017) · Cardiovascular Research · doi:10.1093/cvr/cvx088 · Cited by 48
Dark and bright side of targeting fibroblast growth factor receptor 4 in the liver
Gadaleta, R. M., & Moschetta, A. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2021.07.029 · Cited by 47
FGF-based drug discovery: advances and challenges
Chen, G., Chen, L., Li, X., & Mohammadi, M. (2025) · Nature Reviews Drug Discovery · doi:10.1038/s41573-024-01125-w · Cited by 51
Self-citationYang, C., Wang, C., Ye, M., Jin, C., He, W., Wang, F., McKeehan, W. L., & Luo, Y. (2012) · Nutrition & Metabolism · doi:10.1186/1743-7075-9-94 · Cited by 48
Devaux, C. A., Million, M., & Raoult, D. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01642 · Cited by 50
Physiopathology of Lifestyle Interventions in Non-Alcoholic Fatty Liver Disease (NAFLD)
Carneros, D., López‐Lluch, G., & Bustos, M. (2020) · Nutrients · doi:10.3390/nu12113472 · Cited by 48
Hepatic hormone FGF21 and its analogues in clinical trials
Shao, W., & Jin, T. (2021) · Chronic Diseases and Translational Medicine · doi:10.1016/j.cdtm.2021.08.005 · Cited by 49
Ming, A. Y. K., Yoo, E., Vorontsov, E. N., Altamentova, S. M., Kilkenny, D. M., & Rocheleau, J. V. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.325670 · Cited by 47
(2020) · Advances in clinical chemistry · doi:10.1016/bs.acc.2019.07.012 · Cited by 46
Wang, N., Li, J., Li, S., Guo, X., Wu, T., Wang, W., & Li, D. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.09.143 · Cited by 46
Hepatic FGF21 preserves thermoregulation and cardiovascular function during bacterial inflammation
Huen, S. C., Wang, A., Feola, K. C., Desrouleaux, R., Luan, H. H., Hogg, R. T., Zhang, C., Zhang, Q.-J., Liu, Z., & Medzhitov, R. M. (2021) · The Journal of Experimental Medicine · doi:10.1084/jem.20202151 · Cited by 46
Mellor, H. R. (2014) · Liver International · doi:10.1111/liv.12462 · Cited by 45
Liu, Z., Qi, S., Ζhao, X., Li, M., Ding, S., Lü, J., & Zhang, H. (2016) · Oncotarget · doi:10.18632/oncotarget.7040 · Cited by 45
Zhao, C., Liu, L., Liu, Q., Li, F., Zhang, L., Zhu, F., Shao, T., Barve, S. S., Chen, Y., Li, X., et al. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.08.020 · Cited by 47
Central FGF21 production regulates memory but not peripheral metabolism
Zhou, B., Claflin, K. E., Flippo, K. H., Sullivan, A. I., Asghari, A., Tadinada, S. M., Jensen-Cody, S. O., Abel, T. G., & Potthoff, M. J. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111239 · Cited by 43
Fibroblast growth factor 21 in heart failure
Tucker, W., Tucker, B., Rye, K., & Ong, K. L. (2022) · Heart Failure Reviews · doi:10.1007/s10741-022-10268-0 · Cited by 44
Hamashima, K., Wong, K. W., Sam, T. W., Teo, J. H. J., Taneja, R., Le, M. T. N., Li, Q.-J., Hanna, J. H., Li, H., & Loh, Y. (2023) · Molecular Cell · doi:10.1016/j.molcel.2023.08.010 · Cited by 47
Yu, Y., Zhang, X. H., Ebersole, B., Ribnicky, D., & Wang, Z. Q. (2013) · Scientific Reports · doi:10.1038/srep03142 · Cited by 46
Ge, H., Baribault, H., Vonderfecht, S. L., Lemon, B. D., Weiszmann, J., Gardner, J., Lee, K. J., Gupte, J., Mookherjee, P., Wang, M., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033603 · Cited by 43
The secretory function of adipose tissues in metabolic regulation
Liu, Y., Qian, S., Tang, Y., & Tang, Q. (2024) · Life Metabolism · doi:10.1093/lifemeta/loae003 · Cited by 53
Mouse organic solute transporter alpha deficiency alters FGF15 expression and bile acid metabolism
Lan, T., Rao, A., Haywood, J., Kock, N. D., & Dawson, P. A. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.03.025 · Cited by 42
Li, D., Jing, D., Liu, Z., Chen, Y., Huang, F., & Behnisch, T. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00133 · Cited by 43
Role of Fibroblast Growth Factor 23 (FGF23) and αKlotho in Cancer
Ewendt, F., Feger, M., & Föller, M. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.601006 · Cited by 43
The Role of Fibroblast Growth Factor 19 in Hepatocellular Carcinoma
Chen, Z., Jiang, L., Liang, L., Koral, K., Zhang, Q., Zhao, L., Lu, S., & Tao, J. (2021) · American Journal Of Pathology · doi:10.1016/j.ajpath.2021.04.014 · Cited by 43
Serum fibroblast growth factor 21 levels in polycystic ovary syndrome
Görar, S., Çulha, C., Üç, Z. A., Dellal, F. D., Serter, R., Aral, S., & Aral, Y. (2010) · Gynecological Endocrinology · doi:10.3109/09513590.2010.487587 · Cited by 43
IL-1β inhibits β-Klotho expression and FGF19 signaling in hepatocytes
Zhao, Y., Meng, C., Wang, Y., Huang, H., Liu, W., Zhang, J., Zhao, H., Feng, B., Leung, P. S., & Xia, Y. Y. (2015) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00356.2015 · Cited by 43
Implications of Fibroblast growth factor/Klotho system in glucose metabolism and diabetes
Donate‐Correa, J., Martín‐Núñez, E., Pérez‐Delgado, N., de Fuentes, M. M., Ortíz, A., Fernández, C. M., & Navarro‐González, J. F. (2015) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2015.12.003 · Cited by 44
Molecular elements in FGF19 and FGF21 defining KLB/FGFR activity and specificity
Agrawal, A., Parlee, S. D., Pérez–Tilve, D., Li, P., Pan, J. H., Mroz, P. A., Hansen, A. M. K., Andersen, B., Finan, B., Kharitonenkov, A., et al. (2018) · Molecular Metabolism · doi:10.1016/j.molmet.2018.05.003 · Cited by 42
Endocrine fibroblast growth factors as regulators of metabolic homeostasis
Kurosu, H., & Kuro‐o, M. (2009) · BioFactors · doi:10.1002/biof.12 · Cited by 41
Self-citationLi, H., Sun, H., Qian, B., Feng, W. H., Carney, D., Miller, J. P., Hogan, M. V., & Wang, L. (2019) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3932 · Cited by 41
Role of the fibroblast growth factor 19 in the skeletal system
Chen, H., Li, J., Zhang, D., Zhou, X., & Xie, J. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118804 · Cited by 41
β-Klotho promotes glycolysis and glucose-stimulated insulin secretion via GP130
Geng, L., Liao, B., Jin, L., Yu, J., Zhao, X., Zhao, Y., Zhong, L., Wang, B., Li, J., Liu, J., et al. (2022) · Nature Metabolism · doi:10.1038/s42255-022-00572-2 · Cited by 41
Taniguchi, H., Tanisawa, K., Sun, X., Cao, Z., Oshima, S., Ise, R., Sakamoto, S., & Higuchi, M. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1877 · Cited by 40
Fibroblast growth factor 21 in chronic kidney disease
Anuwatmatee, S., Tang, S., Wu, B. J., Rye, K., & Ong, K. L. (2017) · Clinica Chimica Acta · doi:10.1016/j.cca.2017.11.002 · Cited by 40
Krout, D., Roemmich, J. N., Bundy, A. N., Garcia, R. A. G., Yan, L., & Larson, K. (2018) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2018.03.013 · Cited by 42
Klotho and the Treatment of Human Malignancies
Sachdeva, A., Gouge, J., Kontovounisios, C., Nikolaou, S., Ashworth, A., Lim, K. J., & Chong, I. Y.-S. (2020) · Cancers · doi:10.3390/cancers12061665 · Cited by 41
Schmid, A., Neumann, H., Karrasch, T., Liebisch, G., & Schäffler, A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0148869 · Cited by 40
FGF19 increases mitochondrial biogenesis and fusion in chondrocytes via the AMPKα-p38/MAPK pathway
Kan, S., Pi, C., Zhang, L., Guo, D., Niu, Z., Liu, Y., Duan, M., Pu, X., Bai, M., Zhou, C., et al. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-023-01069-5 · Cited by 41
Adipokines in atherosclerosis: unraveling complex roles
Luo, J., He, Z., Li, Q., Lv, M., Cai, Y., Ke, W., Niu, X., & Zhang, Z. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1235953 · Cited by 44
Halilbasic, E., Fuchs, C. D., Traussnigg, S., & Trauner, M. (2016) · Digestive Diseases · doi:10.1159/000445268 · Cited by 39
Fibroblast Growth Factor 15/19 in Hepatocarcinogenesis
Álvarez‐Sola, G., Uriarte, I., Latasa, M. U., Urtasun, R., Bárcena‐Varela, M., Elizalde, M., Jiménez, M., Rodríguez‐Ortigosa, C. M., Corrales, F. J., Fernández‐Barrena, M. G., et al. (2017) · Digestive Diseases · doi:10.1159/000450905 · Cited by 39
FGF15/19 is required for adipose tissue plasticity in response to thermogenic adaptations
Morón‐Ros, S., Uriarte, I., Berasain, C., Avila, M. A., Sabater, M., Moreno‐Navarrete, J. M., Fernández‐Real, J. M., Giralt, M., Villarroya, F., & Gavaldà‐Navarro, A. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2020.101113 · Cited by 40
Claflin, K. E., Sullivan, A. I., Naber, M. C., Flippo, K. H., Morgan, D. A., Neff, T. J., Jensen-Cody, S. O., Zhu, Z., Zingman, L. V., Rahmouni, K., et al. (2022) · Molecular Metabolism · doi:10.1016/j.molmet.2022.101564 · Cited by 37
Bile Formation and the Enterohepatic Circulation
Dawson, P. A. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-382026-6.00053-1 · Cited by 39
Liver Brain Interactions: Focus on FGF21 a Systematic Review
Prida, E., Álvarez-Delgado, S., Pérez-Lois, R., Soto-Tielas, M., Estany‐Gestal, A., Fernø, J., Seoane, L. M., Quiñones, M., & Al–Massadi, O. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113318 · Cited by 40
Camacho, R. C., Zafian, P., Achanfuo-Yeboah, J., Manibusan, A., & Berger, J. P. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.06.023 · Cited by 38
Fischer, T. H., Faus-Keßler, T., Welzl, G., Simeone, A., Wurst, W., & Prakash, N. (2010) · Developmental Biology · doi:10.1016/j.ydbio.2010.12.017 · Cited by 38
Subphenotypes of inflammatory bowel disease are characterized by specific serum protein profiles
Andersson, E., Bergemalm, D., Kruse, R. L., Neumann, G., D’Amato, M., Repsilber, D., & Halfvarson, J. (2017) · PLoS ONE · doi:10.1371/journal.pone.0186142 · Cited by 39
Libby, A. E., Bales, E. S., Monks, J., Orlicky, D. J., & McManaman, J. L. (2018) · Journal of Lipid Research · doi:10.1194/jlr.m086249 · Cited by 38
Wang, N., Zhao, T., Li, S., Sun, X., Li, Z., Li, Y., Li, D., & Wang, W. (2019) · Obesity · doi:10.1002/oby.22376 · Cited by 38
Sommakia, S., Almaw, N. H., Lee, S. H., Ramadurai, D. K. A., Taleb, I., Kyriakopoulos, C. P., Stubben, C., Jing, L., Campbell, R. A., Alharethi, R. A., et al. (2021) · Circulation Heart Failure · doi:10.1161/circheartfailure.121.008910 · Cited by 38
Luo, Y., Yang, C., Ye, M., Jin, C., Abbruzzese, J. L., Lee, M., Yeung, S. J., & McKeehan, W. L. (2013) · Cancer & Metabolism · doi:10.1186/2049-3002-1-21 · Cited by 36
Izaguirre, M., Gil, M. J., Monreal, I., Montecucco, F., Frühbeck, G., & Catalán, V. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0866-3 · Cited by 41
Enteric Microbiota–Gut–Brain Axis from the Perspective of Nuclear Receptors
Duszka, K., & Wahli, W. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19082210 · Cited by 37
Ritchie, M. M., Hanouneh, I. A., Noureddin, M., Rolph, T., & Alkhouri, N. (2020) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2020.1718104 · Cited by 37
Advances in pharmacotherapy for primary biliary cirrhosis
Mousa, H. S., Lleò, A., Invernizzi, P., Bowlus, C. L., & Gershwin, M. E. (2014) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2015.998650 · Cited by 36
Hyperphosphatemic Familial Tumoral Calcinosis: Genetic Models of Deficient FGF23 Action
Folsom, L. J., & Imel, E. A. (2015) · Current Osteoporosis Reports · doi:10.1007/s11914-015-0254-3 · Cited by 36
Transcriptional Regulation of Fibroblast Growth Factor 21 Expression
Bae, K.-H., Kim, J., & Park, K. (2014) · Endocrinology and Metabolism · doi:10.3803/enm.2014.29.2.105 · Cited by 37
Regulation of fibroblast growth factor 15/19 and 21 on metabolism: in the fed or fasted state
Guan, D., Zhao, L., Chen, D., Yu, B., & Yu, J. (2016) · Journal of Translational Medicine · doi:10.1186/s12967-016-0821-0 · Cited by 36
Bile Formation and the Enterohepatic Circulation
Dawson, P. A. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-809954-4.00041-4 · Cited by 36
FGF21 modulates immunometabolic homeostasis via the ALOX15/15-HETE axis in early liver graft injury
Yang, X., Chen, H. H., Shen, W., Chen, Y., Lin, Z., Zhuo, J., Wang, S., Yang, M., Li, H., He, C., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-52379-2 · Cited by 35
The importance of klotho in phosphate metabolism and kidney disease
Tan, S., Smith, E. R., Hewitson, T. D., Holt, S. G., & Toussaint, N. D. (2014) · Nephrology · doi:10.1111/nep.12268 · Cited by 35
Role of fibroblast growth factors in elicitation of cell responses
Laestander, C., & Engström, W. (2013) · Cell Proliferation · doi:10.1111/cpr.12084 · Cited by 35
Cardiokines as Modulators of Stress-Induced Cardiac Disorders
Planavila, A., Fernández‐Solà, J., & Villarroya, F. (2017) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2017.01.002 · Cited by 38
Álvarez‐Sola, G., Uriarte, I., Latasa, M. U., Jiménez, M., Bárcena‐Varela, M., Santamaría, E., Urtasun, R., Rodríguez‐Ortigosa, C. M., Prìeto, J., Corrales, F. J., et al. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.480 · Cited by 35
High-intensity physical exercise increases serum α -klotho levels in healthy volunteers
Tan, S., Chu, M. M., Toussaint, N. D., Cai, M. M., Hewitson, T. D., & Holt, S. G. (2018) · Journal of Circulating Biomarkers · doi:10.1177/1849454418794582 · Cited by 35
Sciarrillo, C. M., Keirns, B. H., Koemel, N. A., Anderson, K. L., & Emerson, S. R. (2021) · Liver International · doi:10.1111/liv.14802 · Cited by 35
Hao, H., Ma, S., Zheng, C., Wang, Q., Lin, H., Chen, Z., Xie, J., Chen, L., Chen, K., Wang, Y., et al. (2021) · Aging · doi:10.18632/aging.202448 · Cited by 35
Metabolic actions of FGF21: molecular mechanisms and therapeutic implications
Ge, X., Wang, Y., Lam, K. S., & Xu, A. (2012) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2012.06.011 · Cited by 35
Yamamoto, R., Minamizaki, T., Yoshiko, Y., Yoshioka, H., Tanne, K., Aubin, J. E., & Maeda, N. (2010) · Journal of Endocrinology · doi:10.1677/joe-10-0058 · Cited by 34
Novel phosphotyrosine targets of FGFR2IIIb signaling
Luo, Y., Yang, C., Jin, C., Xie, R., Wang, F., & McKeehan, W. L. (2009) · Cellular Signalling · doi:10.1016/j.cellsig.2009.04.004 · Cited by 34
Hu, X., Jogasuria, A. P., Wang, J., Kim, C., Han, Y., Shen, H., Wu, J., & You, M. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.737015 · Cited by 34
de Haan, L. R., van der Lely, S. J., Warps, A. K., Hofsink, Q., Olthof, P. B., de Keijzer, M. J., Lionarons, D. A., Dias, L. M., Bruinsma, B. G., Uygun, K., et al. (2018) · Journal of Clinical and Translational Research · doi:10.18053/jctres.04.201801.001 · Cited by 33
Modulation of energy balance by fibroblast growth factor 21
Ramos, D. C., & Aguilar-Salinas, C. A. (2016) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2016-0023 · Cited by 36
Hou, Z., Ding, Q., Li, Y., Zhao, Z., Yan, F., Li, Y., Wang, X., Xu, J., Chen, W., Wu, G., et al. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.104181 · Cited by 32
Nguyen, A. N., Song, J.-A., Nguyen, M. T., Do, B. H., Kwon, G. G., Park, S. S., Yoo, J., Jang, J., Jin, J., Osborn, M. J., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-16167-x · Cited by 33
Weng, Y., Ishino, T., Sievers, A., Talukdar, S., Chabot, J., Tam, A. S. P., Duan, W., Kerns, K. M., Sousa, E. A., He, T., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-22456-w · Cited by 33
Yadav, P., Khurana, A., Bhatti, J. S., Weiskirchen, R., & Navik, U. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106426 · Cited by 32
Nicolaisen, T. S., Lyster, A. E., Sjøberg, K. A., Haas, D. T., Voldstedlund, C. T., Lundsgaard, A., Jensen, J. K., Madsen, E. M., Nielsen, C. K., Bloch‐Ibenfeldt, M., et al. (2025) · Nature Metabolism · doi:10.1038/s42255-025-01236-7 · Cited by 39
Molecular Mechanisms of Intestinal Transport of Calcium, Phosphate, and Magnesium
Kiela, P. R., & Ghishan, F. K. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-809954-4.00059-1 · Cited by 32
A biparatopic agonistic antibody that mimics fibroblast growth factor 21 ligand activity
Shi, S. Y., Lu, Y., Liu, Z., Stevens, J. L., Murawsky, C. M., Wilson, V., Hu, Z., Richards, W. G., Michaels, M. L., Zhang, J., et al. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.001752 · Cited by 32
A systematic dissection of sequence elements determining β-Klotho and FGF interaction and signaling
Shi, S. Y., Lu, Y., Richardson, J., Min, X., Weiszmann, J., Richards, W. G., Wang, Z., Zhang, Z., Zhang, J., & Li, Y. (2018) · Scientific Reports · doi:10.1038/s41598-018-29396-5 · Cited by 31
FGF23 contains two distinct high-affinity binding sites enabling bivalent interactions with α-Klotho
Suzuki, Y., Kuzina, E. S., An, S. J., Tomé, F., Mohanty, J., Li, W., Lee, S., Liu, Y., Lax, I., & Schlessinger, J. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2018554117 · Cited by 33
A solid-phase PEGylation strategy for protein therapeutics using a potent FGF21 analog
Song, L., Zhu, Y., Wang, H., Belov, A. A., Niu, J., Shi, L., Xie, Y., Ye, C., Li, X., & Huang, Z. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.03.023 · Cited by 32
Jo, S., Kim, S.-G., Choi, Y. J., Joo, N., Cho, G., Choi, S.-R., Kim, E., Kim, H., Kim, H.-J., & Rhim, C. (2009) · International Heart Journal · doi:10.1536/ihj.50.23 · Cited by 32
Fibroblast growth factor 21: a promising therapeutic target in obesity-related diseases
Cheung, B. M. Y., & Deng, H. (2014) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.2014.904745 · Cited by 32
The role of bone in phosphate metabolism
Fukumoto, S. (2008) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.08.031 · Cited by 32
Woolsey, S., Beaton, M. D., Mansell, S. E., Leon‐Ponte, M., Yu, J., Pin, C. L., Adams, P. C., Kim, R. B., & Tirona, R. G. (2016) · Molecular Pharmacology · doi:10.1124/mol.116.104687 · Cited by 32
Fujii, N., Uta, S., Kobayashi, M., Sato, T., Okita, N., & Higami, Y. (2019) · Experimental Gerontology · doi:10.1016/j.exger.2019.01.001 · Cited by 32
Genomic analysis of diet composition finds novel loci and associations with health and lifestylePreprint
Meddens, S. F. W., de Vlaming, R., Bowers, P., Burik, C. A. P., Linnér, R. K., Lee, C. W., Okbay, A., Turley, P., Rietveld, C. A., Fontana, M. A., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/383406 · Cited by 32
Mazzaferro, S., Pasquali, M., Pirrò, G., Rotondi, S., & Tartaglione, L. (2010) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2010.06.028 · Cited by 31
Metadata
- Authors
- Kurosu, H., Choi, M., Ogawa, Y., Dickson, A. S., Goetz, R., Eliseenkova, A. V., Mohammadi, M., Rosenblatt, K. P., Kliewer, S. A., & Kuro-o, M.
- Affiliations
- The University of Texas Southwestern Medical Center (US)
- New York University (US)
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2007-09
- Volume
- 282
- Issue
- 37
- Pages
- 26687-26695
- ISSN
- 0021-9258 (ISSN-L)
- PMC
- PMC2496965
- OpenAlex
- W2048411348
- Cited by
- 748
- References
- 35
- Citations by year
- 2026: 37 · 2025: 24 · 2024: 33 · 2023: 31 · 2022: 55 · 2021: 46 · 2020: 44 · 2019: 48 · 2018: 52 · 2017: 47 · 2016: 38 · 2015: 40 · 2014: 43 · 2013: 43 · 2012: 51
- FWCI
- 10.87
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Ellison Medical Foundation
- Welch Foundation
- Ted Nash Long Life Foundation
- Eisai
- National Institutes of Health (1r01ag015326-01, DK067158)
- National Institute on Aging (R01AG19712, R01AG025326, R01 AG 15326, R01AG019712)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK-067158, R01DK067158)
- National Institute of Dental and Craniofacial Research (R01DE13686, R01DE013686)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fibroblast Growth Factor Research
- Health Sciences › Medicine › Nephrology › Parathyroid Disorders and Treatments
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Keywords
- β-Klotho, Klotho, FGF19, FGF21, fibroblast growth factor 23, fibroblast growth factor receptor, FGFR4, FGFR1, tissue-specific signaling, bile acid metabolism, CYP7A1, hepatocytes, metabolic hormones
- MeSH terms
- Fibroblast Growth Factor-23, Klotho Proteins, Animals, Cholesterol 7-alpha-Hydroxylase, Fibroblast Growth Factors, Humans, Membrane Proteins, Organ Specificity, Phosphorylation, Signal Transduction, Adipocytes, Protein Isoforms, Hepatocytes, 3T3-L1 Cells, Extracellular Signal-Regulated MAP Kinases, Mice, Rats, ErbB Receptors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
